Skip to main content

Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design

Publication ,  Journal Article
Houghton, PJ; Stewart, CF; Thompson, J; Santana, VM; Furman, WL; Friedman, HS
Published in: ONCOLOGY-NEW YORK
August 1, 1998

Duke Scholars

Published In

ONCOLOGY-NEW YORK

ISSN

0890-9091

Publication Date

August 1, 1998

Volume

12

Issue

8

Start / End Page

84 / 93

Publisher

P R R INC
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Houghton, P. J., Stewart, C. F., Thompson, J., Santana, V. M., Furman, W. L., & Friedman, H. S. (1998). Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design. ONCOLOGY-NEW YORK, 12(8), 84–93.
Houghton, P. J., C. F. Stewart, J. Thompson, V. M. Santana, W. L. Furman, and H. S. Friedman. “Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design.” ONCOLOGY-NEW YORK 12, no. 8 (August 1, 1998): 84–93.
Houghton PJ, Stewart CF, Thompson J, Santana VM, Furman WL, Friedman HS. Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design. ONCOLOGY-NEW YORK. 1998 Aug 1;12(8):84–93.
Houghton, P. J., et al. “Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design.” ONCOLOGY-NEW YORK, vol. 12, no. 8, P R R INC, Aug. 1998, pp. 84–93.
Houghton PJ, Stewart CF, Thompson J, Santana VM, Furman WL, Friedman HS. Preclinical and clinical results with irinotecan - Extending principles learned in model systems to clinical trials design. ONCOLOGY-NEW YORK. P R R INC; 1998 Aug 1;12(8):84–93.

Published In

ONCOLOGY-NEW YORK

ISSN

0890-9091

Publication Date

August 1, 1998

Volume

12

Issue

8

Start / End Page

84 / 93

Publisher

P R R INC